Dynein light chain LC8-type 1 (DYNLL1) stands as a versatile protein renowned for its involvement in dynein motor complexes and its extensive interactions with various protein partners. As a constituent of the dynein complex, DYNLL1 contributes to microtubule-based motor activities within cells, but its significance extends beyond this realm as it engages with diverse proteins outside the dynein context, highlighting its broad functional repertoire. Despite the acknowledged importance of DYNLL1 in cellular processes, the modulation of its activity through activators represents an evolving field of interest, unveiling the intricate interactions and potential regulatory checkpoints governing its function. The exploration of DYNLL1 activators introduces a nuanced perspective, considering compounds or entities that can enhance or stimulate its interactions and activities. Activators may operate through different dimensions, where some directly bind to DYNLL1, inducing conformational changes that facilitate interactions with partner proteins. Alternatively, certain activators may indirectly enhance DYNLL1's function by influencing the cellular environment. Molecules capable of modulating intracellular calcium levels or pH, for example, could impact DYNLL1's conformation or binding affinity, recognizing the sensitivity of many protein-protein interactions to such environmental conditions.
Moreover, activators might exert their effects by modulating post-translational modifications of DYNLL1, such as phosphorylation or acetylation. These modifications can profoundly influence protein behavior, offering an additional layer of regulation to DYNLL1's multifaceted functionality. Understanding the diverse mechanisms by which activators can influence DYNLL1 provides insight into the potential strategies for manipulating its activity in various cellular contexts. In conclusion, DYNLL1 activators present a captivating avenue for research, shedding light on the intricate regulatory mechanisms governing this versatile protein. The multifaceted nature of DYNLL1 interactions and the potential impact of activators on its function underscore the complexity of cellular processes and the need for a comprehensive understanding of the molecular mechanisms that dictate protein behavior.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
Staurosporine is a broad-spectrum kinase inhibitor. While primarily known to inhibit kinases, its potential interaction with DYNLL1 could stem from modulation of kinases that indirectly influence DYNLL1's interactions or post-translational modifications. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $103.00 $237.00 | 36 | |
This compound is a protein kinase C (PKC) inhibitor. By modulating PKC activity, it might affect signaling pathways that have downstream effects on proteins like DYNLL1, potentially altering its interactions or activity. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $285.00 $520.00 $1300.00 | 78 | |
As a phosphatase inhibitor, okadaic acid can lead to increased protein phosphorylation. If DYNLL1's function or interactions are regulated by phosphorylation, this compound might indirectly modulate its activity. | ||||||
Calmodulin (human), (recombinant) | 73298-54-1 | sc-471287 | 1 mg | $232.00 | ||
Calmodulin, when bound to calcium, interacts with and activates various enzymes and proteins. If DYNLL1 has any calcium-calmodulin regulated domains or interacts with proteins that do, calmodulin might influence its function. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $45.00 $130.00 $480.00 $4450.00 | 74 | |
This cAMP analog can activate cAMP-dependent pathways. If DYNLL1's activity is modulated by cAMP or proteins in the cAMP pathway, this compound plays a role in its activation. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $97.00 $224.00 | 30 | |
Similar to dibutyryl cAMP, this cAMP analog might influence DYNLL1 if it operates within or is influenced by cAMP-mediated signaling pathways. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin increases intracellular cAMP by activating adenylate cyclase. Elevated cAMP might affect proteins, including potentially DYNLL1, especially if they are part of cAMP-responsive pathways. | ||||||
Dimethyl Sulfoxide (DMSO) | 67-68-5 | sc-202581 sc-202581A sc-202581B | 100 ml 500 ml 4 L | $30.00 $115.00 $900.00 | 136 | |
DMSO can alter protein conformation and cellular processes as a solvent. Its presence indirectly affects DYNLL1's structure or interactions. | ||||||
Manganese(II) chloride beads | 7773-01-5 | sc-252989 sc-252989A | 100 g 500 g | $19.00 $30.00 | ||
Metal ions can act as cofactors for certain proteins. If DYNLL1 requires or binds metal ions, manganese can modulate its conformation or activity. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $47.00 | ||
If DYNLL1 interacts with or is modulated by zinc, this compound can influence its function. | ||||||